INR:0464. denmark vs norway football Wuhan will build a special hospital based on the "Xiaotangshan" model and it will be completed before February 3 " ...

Alphamab Oncology (stock code: 9966.HK) announced that a phase I/II clinical trial (Study ID: JSKN033-102) of JSKN033, a high-concentration subcutaneous co-formulation consisting of anti-HER2 ...

Artificial intelligence (AI)-aided analysis of pathology slides showed potential as a predictive biomarker for non-small cell ...

Just now! The results of the second round of national drug procurement were released CStone Pharmaceuticals initiates ...

INR:6953. rummy 465 Pinduoduo launches another HPV vaccine group sale: spot price as low as 2,599 yuan, and 10 million vaccines sold on the same day Up to 80% price red ...

INR:0053. disawar ka satta bajar Gilead's JAK1 inhibitor shows long-term efficacy in treating rheumatoid arthritis The first domestically produced oral PD- ...

INR:3885. world cup rangoli 2023 Western medicine cannot prescribe Chinese patent medicine? National Health Commission: Free training opportunities are her ...

INR:4658. santa farm experlence near me CStone Pharmaceuticals initiates clinical trial of PD-L1 inhibitor combined with FGFR4 inhibitor Takeda expa ...

INR:2103. kerala lottery monthly chart april 2023 Zaiji Pharmaceuticals' oral PD-L1 inhibitor is approved for clinical trials in China The ...

JSKN033 is the global first high-concentration subcutaneous co-formulation consisting of ADC and PD-L1 immune checkpoint inhibitor in first-in-human clinical trials. Developed on top of the ...

INR:4672. 4rabet website india The new coronavirus vaccine is getting closer. Who will pay for the vaccination of 1.4 billion people? Roche's TIGIT inhibitor ...

A major breakthrough in diabetes treatment! Cell and Science published articles simultaneously Hengrui Medicine Capecitabine Tablets Passed Review for the Second Time CStone Pharmaceuticals initiates ...